IL-27 enhances LPS-induced proinflammatory cytokine production via upregulation of TLR4 expression and signaling in human monocytes

Journal of Immunology

Volumn 188, Issue 2, 2012, Pages 864-873

  Guzzo, Christina ^a   Ayer, Amit ^a   Basta, Sameh ^a   Banfield, Bruce W ^a   Gee, Katrina ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 27; INTERLEUKIN 6; JANUS KINASE 2; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING KINETICS; CELL ACTIVATION; CHEMICAL BINDING; CONTROLLED STUDY; CYTOKINE PRIMING; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOLOGICAL PARAMETERS; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; CELL MEMBRANE; CELL SEPARATION; CELLS, CULTURED; CHEMOKINE CCL3; CHEMOKINE CCL4; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKINS; LIPOPOLYSACCHARIDES; MONOCYTES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84856021914     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101912     Document Type: Article

References (51)

1. Pflanz, S., J. C. Timans, J. Cheung, R. Rosales, H. Kanzler, J. Gilbert, L. Hibbert, T. Churakova, M. Travis, E. Vaisberg, et al. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16: 779-790. (Pubitemid 34786477)
2. Pflanz, S., L. Hibbert, J. Mattson, R. Rosales, E. Vaisberg, J. F. Bazan, J. H. Phillips, T. K. McClanahan, R. de Waal Malefyt, and R. A. Kastelein. 2004. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172: 2225-2231. (Pubitemid 38182370)
3. Guzzo, C., N. F. Che Mat, and K. Gee. 2010. Interleukin-27 induces a STAT1/3- and NF-kappaB-dependent proinflammatory cytokine profile in human monocytes. J. Biol. Chem. 285: 24404-24411.
4. Lucas, S., N. Ghilardi, J. Li, and F. J. de Sauvage. 2003. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 100: 15047-15052. (Pubitemid 37518014)
5. Kalliolias, G. D., and L. B. Ivashkiv. 2008. IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38. J. Immunol. 180: 6325-6333.
6. Schnurr, M., T. Toy, A. Shin, M. Wagner, J. Cebon, and E. Maraskovsky. 2005. Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood 105: 1582-1589. (Pubitemid 40223678)
7. Chuang, T., and R. J. Ulevitch. 2001. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta 1518: 157-161. (Pubitemid 32232289)
8. Chuang, T. H., and R. J. Ulevitch. 2000. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Netw. 11: 372-378.
9. Du, X., A. Poltorak, Y. Wei, and B. Beutler. 2000. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur. Cytokine Netw. 11: 362-371. (Pubitemid 32268893)
10. Rock, F. L., G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95: 588-593. (Pubitemid 28083787)
11. Takeuchi, O., T. Kawai, H. Sanjo, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, K. Takeda, and S. Akira. 1999. TLR6: A novel member of an expanding toll-like receptor family. Gene 231: 59-65. (Pubitemid 29307773)
12. Zarember, K. A., and P. J. Godowski. 2002. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168: 554-561. (Pubitemid 34049553)
13. Chow, J. C., D. W. Young, D. T. Golenbock, W. J. Christ, and F. Gusovsky. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274: 10689-10692.
14. Guha, M., and N. Mackman. 2001. LPS induction of gene expression in human monocytes. Cell. Signal. 13: 85-94. (Pubitemid 32222977)
15. Gioannini, T. L., and J. P.Weiss. 2007. Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells. Immunol. Res. 39: 249-260. (Pubitemid 47574891)
16. Shin, H. J., H. Lee, J. D. Park, H. C. Hyun, H. O. Sohn, D. W. Lee, and Y. S. Kim. 2007. Kinetics of binding of LPS to recombinant CD14, TLR4, and MD-2 proteins. Mol. Cells 24: 119-124. (Pubitemid 47554799)
17. Ma, W., W. Lim, K. Gee, S. Aucoin, D. Nandan, M. Kozlowski, F. Diaz-Mitoma, and A. Kumar. 2001. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 276: 13664-13674.
18. Tsai, C. S., D. L. Chen, S. J. Lin, J. C. Tsai, T. C. Lin, C. Y. Lin, Y. H. Chen, G. S. Huang, H. Y. Tsai, F. Y. Lin, and C. Y. Li. 2009. TNF-alpha inhibits toll-like receptor 4 expression on monocytic cells via tristetraprolin during cardiopulmonary bypass. Shock 32: 40-48.
19. Tamandl, D., M. Bahrami, B. Wessner, G. Weigel, M. Ploder, W. Fürst, E. Roth, G. Boltz-Nitulescu, and A. Spittler. 2003. Modulation of toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness, whereas interleukin-6 enhances lipopolysaccharide activity. Shock 20: 224-229.
20. Bosisio, D., N. Polentarutti, M. Sironi, S. Bernasconi, K. Miyake, G. R. Webb, M. U. Martin, A. Mantovani, and M. Muzio. 2002. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 99: 3427-3431. (Pubitemid 34525326)
21. Mita, Y., K. Dobashi, K. Endou, T. Kawata, Y. Shimizu, T. Nakazawa, and M. Mori. 2002. Toll-like receptor 4 surface expression on human monocytes and B cells is modulated by IL-2 and IL-4. Immunol. Lett. 81: 71-75. (Pubitemid 34159043)
22. Duan, Z., J. E. Bradner, E. Greenberg, R. Levine, R. Foster, J. Mahoney, and M. V. Seiden. 2006. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation. Clin. Cancer Res. 12: 6844-6852. (Pubitemid 44876855)
23. Kamiya, S., T. Owaki, N. Morishima, F. Fukai, J. Mizuguchi, and T. Yoshimoto. 2004. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells. J. Immunol. 173: 3871-3877. (Pubitemid 39280750)
24. Kanda, N., and S. Watanabe. 2008. IL-12, IL-23, and IL-27 enhance human beta-defensin- 2 production in human keratinocytes. Eur. J. Immunol. 38: 1287-1296.
25. Pradhan, A., Q. T. Lambert, and G. W. Reuther. 2007. Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor. Proc. Natl. Acad. Sci. USA 104: 18502-18507. (Pubitemid 350210726)
26. Mowen, K. A., J. Tang, W. Zhu, B. T. Schurter, K. Shuai, H. R. Herschman, and M. David. 2001. Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 104: 731-741. (Pubitemid 32241023)
27. Shen, H., and A. B. Lentsch. 2004. Progressive dysregulation of transcription factors NF-kappa B and STAT1 in prostate cancer cells causes proangiogenic production of CXC chemokines. Am. J. Physiol. Cell Physiol. 286: C840-C847. (Pubitemid 38543813)
28. Che Mat, N. F., X. Zhang, C. Guzzo, and K. Gee. 2011. Interleukin-23-induced interleukin-23 receptor subunit expression is mediated by the Janus kinase/signal transducer and activation of transcription pathway in human CD4 T cells. J. Interferon Cytokine Res. 31: 363-371.
29. Xu, J., D. C. Cole, C. P. Chang, R. Ayyad, M. Asselin, W. Hao, J. Gibbons, S. A. Jelinsky, K. A. Saraf, and K. Park. 2008. Inhibition of the signal transducer and activator of transcription-3 (STAT3) signaling pathway by 4-oxo-1-phenyl- 1,4-dihydroquinoline-3-carboxylic acid esters. J. Med. Chem. 51: 4115-4121. (Pubitemid 352032439)
30. Soliman, A., K. S. Michelsen, H. Karahashi, J. Lu, F. J. Meng, X. Qu, T. R. Crother, S. Rabizadeh, S. Chen, M. S. Caplan, et al. 2010. Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis. PLoS ONE 5: e15044.
31. Shyu, K. G., B. W. Wang, C. M. Lin, and H. Chang. 2010. Cyclic stretch enhances the expression of toll-like receptor 4 gene in cultured cardiomyocytes via p38 MAP kinase and NF-kappaB pathway. J. Biomed. Sci. 17: 15.
32. Natarajan, K., S. Singh, T. R. Burke, Jr., D. Grunberger, and B. B. Aggarwal. 1996. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc. Natl. Acad. Sci. USA 93: 9090-9095. (Pubitemid 26282023)
33. Digicaylioglu, M., and S. A. Lipton. 2001. Erythropoietin-mediated neuro-protection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412: 641-647. (Pubitemid 32772276)
34. Grivennikov, S. I., and M. Karin. 2010. Dangerous liaisons: STAT3 and NFkappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 21: 11-19.
35. Lee, H., A. Herrmann, J. H. Deng, M. Kujawski, G. Niu, Z. Li, S. Forman, R. Jove, D. M. Pardoll, and H. Yu. 2009. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 15: 283-293.
36. Prohinar, P., F. Re, R. Widstrom, D. Zhang, A. Teghanemt, J. P. Weiss, and T. L. Gioannini. 2007. Specific high affinity interactions of monomeric endotoxin. protein complexes with Toll-like receptor 4 ectodomain. J. Biol. Chem. 282: 1010-1017. (Pubitemid 47076551)
37. Greenhill, C. J., S. Rose-John, R. Lissilaa, W. Ferlin, M. Ernst, P. J. Hertzog, A. Mansell, and B. J. Jenkins. 2011. IL-6 trans-signaling modulates TLR4- dependent inflammatory responses via STAT3. J. Immunol. 186: 1199-1208.
38. Baer, M., A. Dillner, R. C. Schwartz, C. Sedon, S. Nedospasov, and P. F. Johnson. 1998. Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kappaB p50. Mol. Cell. Biol. 18: 5678-5689. (Pubitemid 28450519)
39. Carmody, R. J., Q. Ruan, S. Palmer, B. Hilliard, and Y. H. Chen. 2007. Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade. Science 317: 675-678. (Pubitemid 47229968)
40. Driessler, F., K. Venstrom, R. Sabat, K. Asadullah, and A. J. Schottelius. 2004. Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin. Exp. Immunol. 135: 64-73. (Pubitemid 38067929)
41. Perkins, N. D. 2007. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8: 49-62. (Pubitemid 46012014)
42. Hu, X., S. D. Chakravarty, and L. B. Ivashkiv. 2008. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 226: 41-56.
43. Iyer, S. S., A. A. Ghaffari, and G. Cheng. 2010. Lipopolysaccharide- mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages. J. Immunol. 185: 6599-6607.
44. Liu, J., X. Guan, and X. Ma. 2007. Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways. J. Exp. Med. 204: 141-152. (Pubitemid 46148764)
45. Pirhonen, J., J. Sirén, I. Julkunen, and S. Matikainen. 2007. IFN-alpha regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages. J. Leukoc. Biol. 82: 1185-1192. (Pubitemid 350133516)
46. Nomura, F., S. Akashi, Y. Sakao, S. Sato, T. Kawai, M. Matsumoto, K. Nakanishi, M. Kimoto, K. Miyake, K. Takeda, and S. Akira. 2000. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J. Immunol. 164: 3476-3479. (Pubitemid 30169796)
47. Villarino, A. V., and C. A. Hunter. 2004. Biology of recently discovered cytokines: discerning the pro- and anti-inflammatory properties of interleukin-27. Arthritis Res. Ther. 6: 225-233. (Pubitemid 40124374)
48. Wirtz, S., I. Tubbe, P. R. Galle, H. J. Schild, M. Birkenbach, R. S. Blumberg, and M. F. Neurath. 2006. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J. Exp. Med. 203: 1875-1881. (Pubitemid 44188462)
49. Hölscher, C., A. Hölscher, D. Rückerl, T. Yoshimoto, H. Yoshida, T. Mak, C. Saris, and S. Ehlers. 2005. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J. Immunol. 174: 3534-3544. (Pubitemid 40354062)
50. Rückerl, D., M. Hessmann, T. Yoshimoto, S. Ehlers, and C. Hölscher. 2006. Alternatively activated macrophages express the IL-27 receptor alpha chain WSX-1. Immunobiology 211: 427-436.
51. Wang, S., Y. Miyazaki, Y. Shinozaki, and H. Yoshida. 2007. Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1 (IL-27R) deficiency. J. Immunol. 179: 6421-6428.